
Rinotin5 mg
Biopharma Laboratories Ltd.
Levocetirizine Dihydrochloride is a second-generation (low-sedating) antihistamine indicated for the following conditions: Established / FDA-approved uses Seasonal allergic rhinitis — relief of…
Levocetirizine Dihydrochloride is a second-generation (low-sedating) antihistamine indicated for the following conditions:
Levocetirizine Dihydrochloride is generally used as monotherapy for these allergic conditions and does not require combination with another agent to be effective for its labeled indications.
Dosing of Levocetirizine Dihydrochloride is once daily, preferably in the evening, and should be individualized by age, indication, and renal function.
| Age group | Recommended dose |
|---|---|
| Adults and children ≥ 12 years | 5 mg once daily in the evening (some patients may be adequately controlled with 2.5 mg once daily) |
| Children 6–11 years | 2.5 mg once daily in the evening |
| Children 6 months–5 years | 1.25 mg (2.5 mL of oral solution) once daily in the evening, using an age-appropriate liquid formulation |
| Children below 6 months | Safety and efficacy not established; not recommended |
| Renal function (creatinine clearance) | Dose |
|---|---|
| Mild impairment (CrCl 50–80 mL/min) | 2.5 mg once daily |
| Moderate impairment (CrCl 30–50 mL/min) | 2.5 mg once every other day |
| Severe impairment (CrCl 10–30 mL/min) | 2.5 mg twice weekly |
| End-stage renal disease (CrCl < 10 mL/min) / hemodialysis | Contraindicated — see Contraindications |
In pediatric patients (6 months–11 years) with renal impairment, Levocetirizine Dihydrochloride should not be used, as adjusted dosing has not been established in this population. No dose adjustment is required for hepatic impairment alone; in patients with combined hepatic and renal impairment, renal dose-adjustment guidance should be followed. In elderly patients, dosing should be cautious due to a greater likelihood of decreased renal function.
Most adverse effects of Levocetirizine Dihydrochloride are mild and transient. Reported adverse effects include:
Patients should seek prompt medical attention for signs of a severe allergic reaction (swelling of the face/throat, difficulty breathing) or any unusual mood or behavioral changes.
Levocetirizine Dihydrochloride is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.